Welcome to Noile-Immune Biotech


Noile-Immune Biotech is a clinical stage biotechnology company focused on the development and commercialization of next generation CAR-T cells to eradicate solid cancers. 

Our goal is to discover and develop innovative cancer immunotherapies through partnerships with experts in academia including National Cancer Center (NCC) and Yamaguchi University. 

Noile-Immune Biotech was founded in April 2015, and is located in Tokyo, Japan.